BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
BULLFROG AI HOLDINGS, INC. (BFRG) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 14.29 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2026-03-19
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2024-12-31 was 0.00 shares.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2024-09-30 was 0.00 shares.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2024-06-30 was 0.00 shares.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2024-03-31 was 14.29K shares.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2024 was 14.29K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-19 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-19 | 14.29K shares 10-K · filed 2026-03-19 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 14.29K shares 10-Q · filed 2025-11-14 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 14.29K shares 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | 14.29K shares 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |